Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-26

Clinical Trial Update: Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy [Phase 3]

View source ↗

Summary

This is a Phase 3 HIV trial comparing dual antiretroviral therapy to standard triple therapy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Tours | Conditions: HIV | Phase 3 | Status: COMPLETED